Global Biologics and Biosimilars Market Insights, Forecast to 2025

Publisher Name :
Date: 05-Apr-2019
No. of pages: 129
Inquire Before Buying

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.

Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.

Through the research we tend to believe that the growth of biologics industry maybe slow but high profits during the period of patent may attractive. As to biosimilars, now is a changce for newcomers and they will greatly change the industry.

The global Biologics and Biosimilars market is valued at 209400 million US$ in 2018 and will reach 297100 million US$ by the end of 2025, growing at a CAGR of 4.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biologics and Biosimilars market based on company, product type, end user and key regions.

This report studies the global market size of Biologics and Biosimilars in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biologics and Biosimilars in these regions.

This research report categorizes the global Biologics and Biosimilars market by top players/brands, region, type and end user. This report also studies the global Biologics and Biosimilars market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Roche

- Amgen

- AbbVie

- Sanofi-Aventis

- Johnson & Johnson

- Pfizer

- Novo Nordisk

- Eli Lilly

- Novartis

- Merck

- 3sbio

- Changchun High Tech

- CP Guojian

- Biotech

- Gelgen

- Innovent

- Dong Bao

- Ganlee

Market size by Product

- Monoclonal Antibodies

- Interferon

- Erythropoietin

- Insulin

- Vaccines

- Other

Market size by End User

- Tumor

- Diabetes

- Cardiovascular

- Hemophilia

- Other

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Biologics and Biosimilars market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Biologics and Biosimilars market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Biologics and Biosimilars companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Biologics and Biosimilars submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Biologics and Biosimilars are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biologics and Biosimilars market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Biologics and Biosimilars Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Biologics and Biosimilars Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Biologics and Biosimilars Market Size Growth Rate by Product
1.4.2 Monoclonal Antibodies
1.4.3 Interferon
1.4.4 Erythropoietin
1.4.5 Insulin
1.4.6 Vaccines
1.4.7 Other
1.5 Market by End User
1.5.1 Global Biologics and Biosimilars Market Size Growth Rate by End User
1.5.2 Tumor
1.5.3 Diabetes
1.5.4 Cardiovascular
1.5.5 Hemophilia
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biologics and Biosimilars Market Size
2.1.1 Global Biologics and Biosimilars Revenue 2014-2025
2.1.2 Global Biologics and Biosimilars Sales 2014-2025
2.2 Biologics and Biosimilars Growth Rate by Regions
2.2.1 Global Biologics and Biosimilars Sales by Regions
2.2.2 Global Biologics and Biosimilars Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Biologics and Biosimilars Sales by Manufacturers
3.1.1 Biologics and Biosimilars Sales by Manufacturers
3.1.2 Biologics and Biosimilars Sales Market Share by Manufacturers
3.1.3 Global Biologics and Biosimilars Market Concentration Ratio (CR5 and HHI)
3.2 Biologics and Biosimilars Revenue by Manufacturers
3.2.1 Biologics and Biosimilars Revenue by Manufacturers (2014-2019)
3.2.2 Biologics and Biosimilars Revenue Share by Manufacturers (2014-2019)
3.3 Biologics and Biosimilars Price by Manufacturers
3.4 Biologics and Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Biologics and Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biologics and Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into Biologics and Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Biologics and Biosimilars Sales by Product
4.2 Global Biologics and Biosimilars Revenue by Product
4.3 Biologics and Biosimilars Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Biologics and Biosimilars Breakdown Data by End User
6 North America
6.1 North America Biologics and Biosimilars by Countries
6.1.1 North America Biologics and Biosimilars Sales by Countries
6.1.2 North America Biologics and Biosimilars Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Biologics and Biosimilars by Product
6.3 North America Biologics and Biosimilars by End User
7 Europe
7.1 Europe Biologics and Biosimilars by Countries
7.1.1 Europe Biologics and Biosimilars Sales by Countries
7.1.2 Europe Biologics and Biosimilars Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biologics and Biosimilars by Product
7.3 Europe Biologics and Biosimilars by End User
8 Asia Pacific
8.1 Asia Pacific Biologics and Biosimilars by Countries
8.1.1 Asia Pacific Biologics and Biosimilars Sales by Countries
8.1.2 Asia Pacific Biologics and Biosimilars Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Biologics and Biosimilars by Product
8.3 Asia Pacific Biologics and Biosimilars by End User
9 Central & South America
9.1 Central & South America Biologics and Biosimilars by Countries
9.1.1 Central & South America Biologics and Biosimilars Sales by Countries
9.1.2 Central & South America Biologics and Biosimilars Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Biologics and Biosimilars by Product
9.3 Central & South America Biologics and Biosimilars by End User
10 Middle East and Africa
10.1 Middle East and Africa Biologics and Biosimilars by Countries
10.1.1 Middle East and Africa Biologics and Biosimilars Sales by Countries
10.1.2 Middle East and Africa Biologics and Biosimilars Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Biologics and Biosimilars by Product
10.3 Middle East and Africa Biologics and Biosimilars by End User
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Company Business Overview
11.1.3 Roche Biologics and Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Roche Biologics and Biosimilars Products Offered
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Company Business Overview
11.2.3 Amgen Biologics and Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Amgen Biologics and Biosimilars Products Offered
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 Company Business Overview
11.3.3 AbbVie Biologics and Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.3.4 AbbVie Biologics and Biosimilars Products Offered
11.3.5 AbbVie Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi-Aventis Biologics and Biosimilars Products Offered
11.4.5 Sanofi-Aventis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Company Business Overview
11.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Johnson & Johnson Biologics and Biosimilars Products Offered
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Company Business Overview
11.6.3 Pfizer Biologics and Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Pfizer Biologics and Biosimilars Products Offered
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Company Business Overview
11.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Novo Nordisk Biologics and Biosimilars Products Offered
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Company Business Overview
11.8.3 Eli Lilly Biologics and Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Eli Lilly Biologics and Biosimilars Products Offered
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Company Business Overview
11.9.3 Novartis Biologics and Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Novartis Biologics and Biosimilars Products Offered
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Company Business Overview
11.10.3 Merck Biologics and Biosimilars Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Merck Biologics and Biosimilars Products Offered
11.10.5 Merck Recent Development
11.11 3sbio
11.12 Changchun High Tech
11.13 CP Guojian
11.14 Biotech
11.15 Gelgen
11.16 Innovent
11.17 Dong Bao
11.18 Ganlee
12 Future Forecast
12.1 Biologics and Biosimilars Market Forecast by Regions
12.1.1 Global Biologics and Biosimilars Sales Forecast by Regions 2019-2025
12.1.2 Global Biologics and Biosimilars Revenue Forecast by Regions 2019-2025
12.2 Biologics and Biosimilars Market Forecast by Product
12.2.1 Global Biologics and Biosimilars Sales Forecast by Product 2019-2025
12.2.2 Global Biologics and Biosimilars Revenue Forecast by Product 2019-2025
12.3 Biologics and Biosimilars Market Forecast by End User
12.4 North America Biologics and Biosimilars Forecast
12.5 Europe Biologics and Biosimilars Forecast
12.6 Asia Pacific Biologics and Biosimilars Forecast
12.7 Central & South America Biologics and Biosimilars Forecast
12.8 Middle East and Africa Biologics and Biosimilars Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biologics and Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Biologics and Biosimilars Product Picture
Table Biologics and Biosimilars Market Segments
Table Key Manufacturers Biologics and Biosimilars Covered
Table Global Biologics and Biosimilars Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Biologics and Biosimilars Sales Market Share by Product 2014-2025
Figure Monoclonal Antibodies Product Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Interferon Product Picture
Table Major Manufacturers of Interferon
Figure Erythropoietin Product Picture
Table Major Manufacturers of Erythropoietin
Figure Insulin Product Picture
Table Major Manufacturers of Insulin
Figure Vaccines Product Picture
Table Major Manufacturers of Vaccines
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Biologics and Biosimilars Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Tumor
Figure Diabetes
Figure Cardiovascular
Figure Hemophilia
Figure Other
Figure Biologics and Biosimilars Report Years Considered
Figure Global Biologics and Biosimilars Market Size 2014-2025 (Million US$)
Figure Global Biologics and Biosimilars Sales 2014-2025 (K Units)
Table Global Biologics and Biosimilars Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Biologics and Biosimilars Sales by Regions 2014-2019 (K Units)
Table Global Biologics and Biosimilars Sales Market Share by Regions 2014-2019
Figure Global Biologics and Biosimilars Sales Market Share by Regions 2014-2019
Figure 2018 Global Biologics and Biosimilars Sales Market Share by Regions
Table Global Biologics and Biosimilars Revenue by Regions 2014-2019 (Million US$)
Table Global Biologics and Biosimilars Revenue Market Share by Regions 2014-2019
Figure Global Biologics and Biosimilars Revenue Market Share by Regions 2014-2019
Figure 2018 Global Biologics and Biosimilars Revenue Market Share by Regions
Table Global Biologics and Biosimilars Sales by Manufacturers (2014-2019) (K Units)
Table Global Biologics and Biosimilars Sales Share by Manufacturers (2014-2019)
Figure Global Biologics and Biosimilars Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Biologics and Biosimilars Revenue by Manufacturers (2014-2019) (Million USD)
Table Biologics and Biosimilars Revenue Share by Manufacturers (2014-2019)
Figure Biologics and Biosimilars Value Share by Manufacturers in 2018
Table Key Manufacturers Biologics and Biosimilars Price (2014-2019) (USD/Unit)
Table Biologics and Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Biologics and Biosimilars Product Type
Table Date of International Manufacturers Enter into Biologics and Biosimilars Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Biologics and Biosimilars Sales by Product (2014-2019) (K Units)
Table Global Biologics and Biosimilars Sales Share by Product (2014-2019)
Figure Global Biologics and Biosimilars Sales Market Share by Product (2014-2019)
Figure Global Biologics and Biosimilars Sales Market Share by Product in 2018
Table Global Biologics and Biosimilars Revenue by Product (2014-2019) (Million US$)
Table Global Biologics and Biosimilars Revenue Share by Product (2014-2019)
Figure Global Biologics and Biosimilars Revenue Market Share by Product (2014-2019)
Figure Global Biologics and Biosimilars Revenue Market Share by Product in 2018
Table Biologics and Biosimilars Price by Product 2014-2019 (USD/Unit)
Table Global Biologics and Biosimilars Sales by End User (2014-2019) (K Units)
Table Global Biologics and Biosimilars Sales Share by End User (2014-2019)
Figure Global Sales Biologics and Biosimilars Market Share by End User (2014-2019)
Figure Global Sales Biologics and Biosimilars Market Share by End User in 2018
Figure North America Biologics and Biosimilars Sales Growth Rate 2014-2019 (K Units)
Figure North America Biologics and Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table North America Biologics and Biosimilars Sales by Countries (2014-2019) (K Units)
Table North America Biologics and Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 North America Biologics and Biosimilars Sales Market Share by Countries
Table North America Biologics and Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table North America Biologics and Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Biologics and Biosimilars Revenue Market Share by Countries
Figure United States Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure United States Biologics and Biosimilars Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Canada Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table North America Biologics and Biosimilars Sales by Product (2014-2019) (K Units)
Table North America Biologics and Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 North America Biologics and Biosimilars Market Share by Product
Table North America Biologics and Biosimilars Sales by End User (2014-2019) (K Units)
Table North America Biologics and Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 North America Biologics and Biosimilars Market Share by End User
Figure Europe Biologics and Biosimilars Sales Growth Rate 2014-2019 (K Units)
Figure Europe Biologics and Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Biologics and Biosimilars Sales by Countries (2014-2019) (K Units)
Table Europe Biologics and Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Biologics and Biosimilars Sales Market Share by Countries
Table Europe Biologics and Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Europe Biologics and Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Biologics and Biosimilars Revenue Market Share by Countries
Figure Germany Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Germany Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure France Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure France Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure UK Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Italy Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Russia Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Biologics and Biosimilars Sales by Product (2014-2019) (K Units)
Table Europe Biologics and Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 Europe Biologics and Biosimilars Market Share by Product
Table Europe Biologics and Biosimilars Sales by End User (2014-2019) (K Units)
Table Europe Biologics and Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 Europe Biologics and Biosimilars Market Share by End User
Figure Asia Pacific Biologics and Biosimilars Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Biologics and Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Biologics and Biosimilars Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Biologics and Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Biologics and Biosimilars Sales Market Share by Countries
Table Asia Pacific Biologics and Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Biologics and Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Biologics and Biosimilars Revenue Market Share by Countries
Figure China Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure China Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Japan Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Korea Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure India Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure India Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Australia Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Biologics and Biosimilars Sales by Product (2014-2019) (K Units)
Table Asia Pacific Biologics and Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Biologics and Biosimilars Market Share by Product
Table Asia Pacific Biologics and Biosimilars Sales by End User (2014-2019) (K Units)
Table Asia Pacific Biologics and Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Biologics and Biosimilars Market Share by End User
Figure Central & South America Biologics and Biosimilars Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Biologics and Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Biologics and Biosimilars Sales by Countries (2014-2019) (K Units)
Table Central & South America Biologics and Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Biologics and Biosimilars Sales Market Share by Countries
Table Central & South America Biologics and Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Biologics and Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Biologics and Biosimilars Revenue Market Share by Countries
Figure Brazil Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Biologics and Biosimilars Sales by Product (2014-2019) (K Units)
Table Central & South America Biologics and Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Biologics and Biosimilars Market Share by Product
Table Central & South America Biologics and Biosimilars Sales by End User (2014-2019) (K Units)
Table Central & South America Biologics and Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Biologics and Biosimilars Market Share by End User
Figure Middle East and Africa Biologics and Biosimilars Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Biologics and Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Biologics and Biosimilars Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries
Table Middle East and Africa Biologics and Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries
Figure GCC Countries Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Biologics and Biosimilars Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Biologics and Biosimilars Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Biologics and Biosimilars Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Biologics and Biosimilars Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Biologics and Biosimilars Market Share by Product
Table Middle East and Africa Biologics and Biosimilars Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Biologics and Biosimilars Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Biologics and Biosimilars Market Share by End User
Table Roche Company Details
Table Roche Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Amgen Company Details
Table Amgen Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table AbbVie Company Details
Table AbbVie Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Sanofi-Aventis Company Details
Table Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi-Aventis Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Pfizer Company Details
Table Pfizer Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novo Nordisk Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Novartis Company Details
Table Novartis Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Biologics and Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table 3sbio Company Details
Table Changchun High Tech Company Details
Table CP Guojian Company Details
Table Biotech Company Details
Table Gelgen Company Details
Table Innovent Company Details
Table Dong Bao Company Details
Table Ganlee Company Details
Table Global Biologics and Biosimilars Sales Forecast by Regions 2019-2025 (K Units)
Table Global Biologics and Biosimilars Sales Market Share Forecast by Regions 2019-2025
Table Global Biologics and Biosimilars Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Biologics and Biosimilars Revenue Market Share Forecast by Regions 2019-2025
Table Global Biologics and Biosimilars Sales Forecast by Product 2019-2025 (K Units)
Table Global Biologics and Biosimilars Sales Market Share Forecast by Product 2019-2025
Table Global Biologics and Biosimilars Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Biologics and Biosimilars Revenue Market Share Forecast by Product 2019-2025
Table Global Biologics and Biosimilars Sales Forecast by End User 2019-2025 (K Units)
Table Global Biologics and Biosimilars Sales Market Share Forecast by End User 2019-2025
Figure North America Biologics and Biosimilars Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Biologics and Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Biologics and Biosimilars Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Biologics and Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Biologics and Biosimilars Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Biologics and Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Biologics and Biosimilars Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Biologics and Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Biologics and Biosimilars Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Biologics and Biosimilars Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Biologics and Biosimilars Value Chain
Table Biologics and Biosimilars Customers List
Table Biologics and Biosimilars Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Oncology Biosimilars Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 31-Mar-2020        Price: US 3000 Onwards        Pages: 149
    Oncology Biosimilars Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Oncology Biosimilars industry with a focus on the Chinese market. The report provides key statistics on the market status of the Oncology Biosimilars manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Onc......
  • Global Adalimumab Biosimilar Market Research Report 2015-2025
    Published: 28-Mar-2020        Price: US 1800 Onwards        Pages: 79
    Summary The global Adalimumab Biosimilar market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned a......
  • Global Adalimumab Biosimilar Market Status and Future Forecast 2015-2025
    Published: 25-Mar-2020        Price: US 4500 Onwards        Pages: 123
    Summary The report forecast globalAdalimumab Biosimilar market to grow to reach xxx Million USD in 2020 withA CAGR of xx% during the period 2020-2025. The report offers detailed coverage ofAdalimumab Biosimilar industryAnd main market trends. The market research includes historicalAnd forecast market data, demand,Application details, price trends,And company shares of the leadingAdalimumab Biosimilar by geography. The report splits the market size, by volumeAnd valu......
  • Biosimilars Market by Product (Insulin, Interferon, Etanercept, Infliximab, Rituximab, Glucagon, Calcitonin), Manufacturing (In-house, Contract) & Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease), Region – Global Forecast to 2025
    Published: 24-Mar-2020        Price: US 5650 Onwards        Pages: 184
    “The global biosimilars  market size is projected to register a CAGR of 24.7% during the forecast period.” The global biosimilars market size is projected to reach USD 35.7 billion by 2025 from USD 11.8 billion in 2020, at a CAGR of 24.7%. Growth in this industry is driven by the rising incidence of chronic diseases and the increasing demand for biosimilars due to their cost-effectiveness. On the other hand, complexities in manufacturing restraining t......
  • Global Oncology Biosimilars Market Research Report 2020
    Published: 23-Mar-2020        Price: US 2900 Onwards        Pages: 95
    The global Oncology Biosimilars market is valued at US$ 474.2 million in 2020 is expected to reach US$ 2965 million by the end of 2026, growing at a CAGR of 29.6% during 2021-2026. This report focuses on Oncology Biosimilars volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Oncology Biosimilars market size by analysing historical data and future prospect. Regionally, this report focuses on seve......
  • Global Oncology Biosimilars Market Research Report 2015-2025
    Published: 20-Mar-2020        Price: US 1800 Onwards        Pages: 88
    Summary The global Oncology Biosimilars market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as......
  • Global Biologics and Biosimilars Market Status and Future Forecast 2015-2025
    Published: 20-Mar-2020        Price: US 4500 Onwards        Pages: 209
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • Global Biosimilars Market Status and Future Forecast 2015-2025
    Published: 19-Mar-2020        Price: US 4500 Onwards        Pages: 144
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. The report forecast global Biosimilars market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025. The report offers detailed coverage of Biosimilars industry and main market trends. The market research include......
  • Global and China Oncology Biosimilars Market 2020 by Manufacturers, Type and Application, Forecast to 2025
    Published: 18-Mar-2020        Price: US 3980 Onwards        Pages: 93
    Market Overview The global Oncology Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 28.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1323.1 million by 2025, from USD 487.9 million in 2019. The Oncology Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs